Doxepin Hydrochloride NDC 69238-1733

NDC codes

FDA NDC Directory

Product NDC (as listed)69238-1733Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69238-1733Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69238-1733-6	69238173306	1 TUBE in 1 CARTON (69238-1733-6) / 45 g in 1 TUBEMarketed from Aug 21, 2023

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Doxepin Hydrochloride
Generic name (nonproprietary): doxepin hydrochloride
Active ingredients: Doxepin hydrochloride — 50 mg/g
Dosage form: Cream
Route: Topical
Labeler: Amneal Pharmaceuticals NY LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212357
Marketing start: Aug 21, 2023
Listing expires: Dec 31, 2026
Identifiers: Product ID 69238-1733_f44f392e-0f43-4e5d-a2c4-0b15387d67acSPL ID f44f392e-0f43-4e5d-a2c4-0b15387d67acSPL set ID dd8d5edd-7b08-4061-86e6-c4179da89c0dRxCUI 1000091UNII 3U9A0FE9N5UPC 0369238173369
Pharmacologic class: Tricyclic Antidepressant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469238173306 followed by a unit qualifier and the quantity

Package 69238-1733-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 17, 2023.

Indications (excerpt from the label)

INDICATIONS AND USAGE Doxepin HCl cream, 5% is indicated for the short-term (up to 8 days) management of moderate pruritus in adult patients with atopic dermatitis or lichen simplex chronicus (see DOSAGE AND ADMINISTRATION ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)